Structure Therapeutics
Structure Therapeutics (NASDAQ: GPCR) is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, developing novel oral small-molecule medicines for chronic diseases with significant unmet medical need. The company applies a structure-based drug discovery platform focused on G protein-coupled receptors (GPCRs) to design once-daily oral therapies, with lead programs centered on oral small-molecule GLP-1 receptor agonists for obesity and metabolic disease. This is a company profile in the API Evangelist network; Structure Therapeutics maintains a corporate and investor web presence, but no public developer API surface was found during enrichment.
Structure Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biotechnology, Pharmaceuticals, and Drug Discovery.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API